CD274 and neoplasm: PD-L1 expression in tumor cells and lymphocytes was associated with a poor prognosis in a study evaluating the expression of CD80, CD86, and PD-L1 in both the tumor and lymphocytes in renal cell tumor cases in the literature, whereas CD80 and CD86 expressions were not correlated with the prognosis (2).